ANI Pharmaceuticals, Inc.
ANIP
$61.46
-$1.81-2.85%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 57.48% | -956.67% | -112.56% | 1,476.36% | -88.38% |
| Total Depreciation and Amortization | 43.51% | 7.15% | 0.07% | -3.34% | -0.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.59% | -1.78% | 316.16% | -841.82% | -59.27% |
| Change in Net Operating Assets | -169.31% | 356.43% | 55.94% | -136.78% | 399.43% |
| Cash from Operations | 27.14% | -28.37% | -4.68% | -59.17% | 39.08% |
| Capital Expenditure | 50.25% | -8.16% | 2.88% | -101.01% | -31.05% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | 97.91% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 86.37% | -- | -- | -- | 11.16% |
| Cash from Investing | 97.32% | -8,857.56% | -149.80% | 286.92% | -4.96% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 99.95% | -39,150.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | 42.62% | 18.61% | -61.21% | 31.59% | -64.72% |
| Repurchase of Common Stock | 53.24% | 47.69% | 84.99% | -3,649.35% | 65.52% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 0.25% | -0.25% | 0.00% | 0.00% |
| Other Financing Activities | 89.76% | -- | 100.00% | 0.00% | -- |
| Cash from Financing | -101.69% | 20,143.39% | 92.64% | -65.51% | -417.39% |
| Foreign Exchange rate Adjustments | -426.67% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.87% | -925.96% | 54.00% | -73.34% | -10.61% |
